Palatin Technologies Inc Revenue Growth Rates (PTN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Palatin Technologies Inc   (NYSEAMER: PTN)
 

PTN's Revenue Growth by Quarter and Year

Palatin Technologies Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PTN Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March 3.92
2nd Quarter December 0.12
1st Quarter September 8.85
FY 12.89

PTNs Annual Revenue
Palatin Technologies Inc 's Revenue in the fiscal year 2025 $ 0.00 millions
Palatin Technologies Inc 's Revenue in the fiscal year 2024 $ 4.49 millions
Palatin Technologies Inc 's Revenue in the fiscal year 2023 $ 4.85 millions
Palatin Technologies Inc 's Revenue in the fiscal year 2022 $ 1.47 millions
Palatin Technologies Inc 's Revenue in the fiscal year 2021 $ -0.19 millions




PTN Revenue third quarter 2026 Y/Y Growth Comment
Palatin Technologies Inc in the third quarter 2026 achieved Revenue of $ 3.92 millions compare to recorded in same quarter a year ago.

Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Revenue growth. While Palatin Technologies Inc ' s Revenue no change of 0% ranks overall at the positon no. 6 in the third quarter 2026.


PTN Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter June - - -80.11 % 109.52 %
3rd Quarter March - - - 445.45 %
2nd Quarter December - - 97.09 % 312 %
1st Quarter September - - 142.53 % 443.75 %
FY   - - -7.61 % -

Financial Statements
Palatin Technologies Inc 's third quarter 2026 Revenue $ 3.92 millions PTN's Income Statement
Palatin Technologies Inc 's third quarter 2025 Revenue $ 0.00 millions Quarterly PTN's Income Statement


PTN Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter June - - - 46.67 %
3rd Quarter March 3167.23 % - - 16.5 %
2nd Quarter December -98.64 % - -3.79 % 18.39 %
1st Quarter September - - 19.89 % 3.57 %
FY (Year on Year)   - - -7.61 % -


Back to PTN Growth rate Comparisons >> Back to PTN Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #4
Overall #6

Revenue Y/Y Growth Statistics
High Average Low
3278.84 % 97.33 % -100 %
(Mar 31 2026)   (Sep 30 2024)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #4
Overall #6
Revenue Y/Y Growth Statistics
High Average Low
3278.84 % 97.33 % -100 %
(Mar 31 2026)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Palatin Technologies Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3278.84 % 97.33 % -100 %
(Mar 31 2026)  


PTN's III. Quarter Q/Q Revenue Comment
Palatin Technologies Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 3167.23%, to $ 3.92 millions, from $0.12 millions in the second quarter.
PTN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Palatin Technologies Inc 's Revenue growth quarter on quarter, overall rank is 6.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #4
Overall #6
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #4
Overall #6
Revenue Q/Q Growth Statistics
High Average Low
3278.84 % 97.33 % -100 %
(Mar 31 2026)  


PTN's III. Quarter Q/Q Revenue Comment
Palatin Technologies Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 3167.23%, to $ 3.92 millions, from $0.12 millions in the second quarter.
PTN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Palatin Technologies Inc 's Revenue growth quarter on quarter, overall rank is 6.


Palatin Technologies Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Mar 31 2026 period, Palatin Technologies Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Palatin Technologies Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2026 period, Palatin Technologies Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Palatin Technologies Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PTN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Trisalus Life Sciences Inc -0.03%$ -0.035 millions
Adma Biologics Inc -0.30%$ -0.304 millions
Vaso Corporation-0.54%$ -0.545 millions
60 Degrees Pharmaceuticals Inc -0.92%$ -0.922 millions
Cytosorbents Corporation-0.95%$ -0.945 millions
Conmed Corporation-1.31%$ -1.310 millions
Neuropace Inc -1.32%$ -1.316 millions
Bio techne Corp-1.35%$ -1.353 millions
Schrodinger Inc -1.62%$ -1.619 millions
United Therapeutics Corporation-1.62%$ -1.624 millions
Prokidney Corp -1.74%$ -1.739 millions
Sarepta Therapeutics Inc -1.89%$ -1.887 millions
Fortrea Holdings Inc -2.27%$ -2.272 millions
Ultragenyx Pharmaceutical Inc -2.36%$ -2.363 millions
Teladoc Health Inc -2.47%$ -2.467 millions
Fonar Corporation-2.55%$ -2.551 millions
Puma Biotechnology Inc -2.59%$ -2.593 millions
Coya Therapeutics Inc -2.61%$ -2.612 millions
10x Genomics Inc -2.76%$ -2.763 millions
Plus Therapeutics Inc -2.93%$ -2.927 millions
Infusystem Holdings Inc-2.97%$ -2.973 millions
Solventum Corporation-3.04%$ -3.043 millions
Milestone Scientific Inc -3.15%$ -3.153 millions
Organon and Co -3.50%$ -3.503 millions
Fulgent Genetics Inc -3.89%$ -3.894 millions
Igc Pharma Inc -3.94%$ -3.939 millions
Carlisle Companies Incorporated-3.99%$ -3.988 millions
Harvard Bioscience Inc -4.44%$ -4.437 millions
Castle Biosciences Inc -4.90%$ -4.897 millions
Prestige Consumer Healthcare Inc -4.95%$ -4.953 millions


About Palatin Technologies Inc Revenue Growth Rates (PTN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Palatin Technologies Inc (CIK 911216).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-022778
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Palatin Technologies Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.